X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (201) 201
adult (143) 143
index medicus (143) 143
male (143) 143
infectious diseases (137) 137
female (136) 136
middle aged (111) 111
hiv infections - drug therapy (108) 108
immunology (88) 88
hiv (83) 83
aids (59) 59
antiretroviral therapy (59) 59
cd4 lymphocyte count (58) 58
aged (52) 52
cohort studies (50) 50
virology (50) 50
human immunodeficiency virus--hiv (49) 49
hiv infections - virology (43) 43
microbiology (43) 43
viral load (43) 43
treatment outcome (41) 41
anti-hiv agents - therapeutic use (40) 40
hiv infection (40) 40
antiviral agents (38) 38
mortality (38) 38
risk factors (38) 38
drug therapy (37) 37
young adult (37) 37
adolescent (36) 36
antiretroviral therapy, highly active (35) 35
hiv infections - immunology (35) 35
antiretroviral drugs (33) 33
health aspects (33) 33
infections (31) 31
hiv infections - complications (27) 27
hiv-1 (27) 27
research (27) 27
aids/hiv (26) 26
hiv-1 - drug effects (26) 26
pharmacology & pharmacy (26) 26
care and treatment (25) 25
article (24) 24
drug therapy, combination (24) 24
europe (24) 24
infection (24) 24
human-immunodeficiency-virus (23) 23
prospective studies (23) 23
analysis (22) 22
prognosis (22) 22
epidemiology (21) 21
highly active antiretroviral therapy (21) 21
active antiretroviral therapy (20) 20
antiretroviral agents (20) 20
risk (20) 20
therapy (20) 20
hiv-1-infected patients (19) 19
individuals (19) 19
time factors (19) 19
acquired immune deficiency syndrome--aids (18) 18
anti-retroviral agents - therapeutic use (18) 18
drug resistance, viral (18) 18
hiv patients (18) 18
medicine (18) 18
patients (18) 18
rna, viral - blood (18) 18
disease progression (17) 17
hiv infections - mortality (17) 17
abridged index medicus (16) 16
dosage and administration (16) 16
germany (16) 16
medicine, general & internal (16) 16
protease inhibitors (16) 16
610 medicine & health (15) 15
animals (15) 15
cohort (15) 15
hematology (15) 15
hiv infections - epidemiology (15) 15
prevalence (15) 15
viruses (15) 15
adults (14) 14
aged, 80 and over (14) 14
clinical trials (14) 14
diagnosis (14) 14
europe - epidemiology (14) 14
hiv infections - blood (14) 14
infected patients (14) 14
resistance (14) 14
drug resistance (13) 13
era (13) 13
hiv-1 - genetics (13) 13
immunodeficiency-virus type-1 (13) 13
internal medicine (13) 13
life sciences (13) 13
survival (13) 13
acquired immunodeficiency syndrome - drug therapy (12) 12
anti-hiv agents - administration & dosage (12) 12
double-blind method (12) 12
hiv protease inhibitors - therapeutic use (12) 12
incidence (12) 12
medicine, research & experimental (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Infectious Diseases, ISSN 0022-1899, 10/2008, Volume 198, Issue 8, pp. 1113 - 1122
Background. Vicriviroc (VCV) is a CCR5 antagonist with nanomolar activity against human immunodeficiency virus (HIV) replication in vitro and in vivo. We... 
HIV/AIDS | Tropisms | RNA | HIV | Placebos | Viruses | AIDS | Infections | Dosage | HIV 1 | Virology | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | PROGNOSTIC VALUE | CCR5 ANTAGONIST | INDIVIDUALS | ANTIRETROVIRAL-DRUG-RESISTANCE | SYNCYTIUM-INDUCING PHENOTYPE | EPIDEMIOLOGY | DISEASE PROGRESSION | Piperazines - administration & dosage | Lamivudine - administration & dosage | Humans | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | HIV-1 - physiology | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | CCR5 Receptor Antagonists | Benzoxazines - administration & dosage | Double-Blind Method | Zidovudine - adverse effects | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | HIV Infections - virology | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Piperazines - therapeutic use | Piperazines - adverse effects | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | HIV Infections - drug therapy | Zidovudine - therapeutic use | Lamivudine | Dosage and administration | HIV (Viruses) | Drug therapy | Zidovudine | Index Medicus | Abridged Index Medicus
Journal Article
Nature Structural and Molecular Biology, ISSN 1545-9993, 10/2016, Volume 23, Issue 10, pp. 906 - 915
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2017, Volume 23, Issue 2, pp. 185 - 191
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 3, pp. 322 - 329
Journal Article
PLoS medicine, ISSN 1549-1277, 2013, Volume 10, Issue 9, p. e1001510
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 07/2018, Volume 320, Issue 4, pp. 379 - 396
Journal Article
Nature, ISSN 0028-0836, 06/2015, Volume 522, Issue 7557, pp. 487 - 491
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was largely ineffective in pre-clinical and clinical settings and was... 
THERAPY | VIRUS | HIV-1 NEUTRALIZATION | GENETIC-DETERMINANTS | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | IN-VIVO | VACCINE | MICE | MONOCLONAL-ANTIBODIES | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Viremia - therapy | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Male | Case-Control Studies | HIV Envelope Protein gp120 - immunology | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | Time Factors | HIV-1 - chemistry | Antibodies, Neutralizing - therapeutic use | Adult | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Immunization, Passive - methods | HIV-1 - drug effects | HIV Infections - virology | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Neutralizing - pharmacology | HIV Antibodies - administration & dosage | Viral Load - immunology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | HIV Infections - therapy | Viremia - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Virus diseases | Physiological aspects | Antibodies | HIV infection | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV | Immunotherapy | Infections | Drug dosages | Binding sites | Immune system
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 6, p. e11110
Circulating plasmacytoid dendritic cells (pDC) decline during HIV-1 infection, but at the same time they express markedly higher levels of interferon alpha... 
RNA LEVELS | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | IMMUNE ACTIVATION | PERIPHERAL-BLOOD | HIV-1-INFECTED PATIENTS | ACTIVE-ANTIRETROVIRAL-THERAPY | PROGNOSTIC VALUE | BLOOD MONONUCLEAR-CELLS | T-CELLS | I INTERFERON | Humans | Male | Lymph Nodes - secretion | DNA Primers | Receptors, CCR7 - blood | Dendritic Cells - secretion | Flow Cytometry | HIV-1 - isolation & purification | Base Sequence | Interferon-alpha - secretion | Adult | Female | HIV Infections - metabolism | Infection | Care and treatment | Dendritic cells | Cell death | Interferon alpha | HIV patients | Development and progression | Disease susceptibility | Biological response modifiers | T cells | HIV (Viruses) | Health aspects | Cell proliferation | CC chemokine receptors | CD40 antigen | CD86 antigen | Otolaryngology | Viruses | Lymphocytes T | Infections | Lymph nodes | Homing | α-Interferon | Immunology | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Peripheral blood | Cell cycle | Immunopathogenesis | Drug therapy | Antiretroviral drugs | Lymphatic system | Immune response | Internal medicine | CCR7 protein | Glycoproteins | Gene expression | Patients | Virology | CD4 antigen | Medicine | Studies | CD83 antigen | Interferon | Cell migration | Viral infections | Lymph | Apoptosis | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article